{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:09:40Z","timestamp":1786734580902,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jep.2010.02.012","type":"journal-article","created":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T09:31:04Z","timestamp":1267263064000},"page":"685-692","source":"Crossref","is-referenced-by-count":57,"title":["Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice"],"prefix":"10.1016","volume":"128","author":[{"given":"Qing-Hua","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Qing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Zhong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Dong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2010.02.012_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CEJ.0b013e328313631a","article-title":"A prospective study of gout and cancer","volume":"18","author":"Boffetta","year":"2009","journal-title":"European Journal of Cancer Prevention"},{"key":"10.1016\/j.jep.2010.02.012_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11926-004-0075-3","article-title":"Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase","volume":"6","author":"Bomalaski","year":"2004","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.jep.2010.02.012_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/ajprenal.2000.278.6.F853","article-title":"Structure of renal organic anion and cation transporters","volume":"278","author":"Burckhardt","year":"2000","journal-title":"American Journal of Physiology and Renal Physiology"},{"key":"10.1016\/j.jep.2010.02.012_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/clinchem\/17.3.158","article-title":"A simplified alkaline phosphotungstate assay for uric acid in serum","volume":"17","author":"Carroll","year":"1971","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.jep.2010.02.012_bib5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/meta.2001.26705","article-title":"Clinical features of familial gout and effects of probable genetic association between gout and its related disorders","volume":"50","author":"Chen","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.jep.2010.02.012_bib6","unstructured":"Chinese Medicine Pharmacology Research Technology, 1994. People's Medical Publishing House, Beijing, pp. 1103.(in Chinese)."},{"key":"10.1016\/j.jep.2010.02.012_bib7","series-title":"Pharmacopoeia of the People's Republic of China","author":"Chinese Pharmacopoeia Committee","year":"2005"},{"key":"10.1016\/j.jep.2010.02.012_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi","year":"2007","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.jep.2010.02.012_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.jep.2010.02.012_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4684-5673-8_50","article-title":"The activity of AA-193, a new uricosuric agent, in animals","volume":"253","author":"Dan","year":"1989","journal-title":"Advances in Experimental Medical Biology"},{"key":"10.1016\/j.jep.2010.02.012_bib11","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.69.8.594","article-title":"Asymptomatic hyperuricemia: to treat or not to treat","volume":"69","author":"Dincer","year":"2002","journal-title":"Cleve Clinical Journal of Medicine"},{"key":"10.1016\/j.jep.2010.02.012_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1520-6017(200104)90:4<397::AID-JPS1000>3.0.CO;2-D","article-title":"Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters","volume":"90","author":"Dresser","year":"2001","journal-title":"Journal of Pharmaceutical Science"},{"key":"10.1016\/j.jep.2010.02.012_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10157-005-0368-5","article-title":"Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease","volume":"9","author":"Enomoto","year":"2005","journal-title":"Clinical Experiments in Nephrology"},{"key":"10.1016\/j.jep.2010.02.012_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00207.2007","article-title":"Multiple organic anion transporters contribute to net renal excretion of uric acid","volume":"33","author":"Eraly","year":"2008","journal-title":"Physiological Genomics"},{"key":"10.1016\/j.jep.2010.02.012_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11926-001-0048-8","article-title":"Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient","volume":"3","author":"Fam","year":"2001","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.jep.2010.02.012_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.2005121331","article-title":"Serum uric acid: a risk factor and a target for treatment?","volume":"17","author":"Feig","year":"2006","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1016\/j.jep.2010.02.012_bib17","first-page":"146","article-title":"Treat acute gout with coix seed of 51 cases","volume":"9","author":"Fu","year":"2009","journal-title":"Chinese Journal of Modern Drug Application"},{"key":"10.1016\/j.jep.2010.02.012_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/mp060073a","article-title":"OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1)","volume":"4","author":"Glube","year":"2007","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.jep.2010.02.012_bib19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/jpet.103.058388","article-title":"Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes","volume":"308","author":"Grover","year":"2004","journal-title":"Journal of Pharmacology and Experimental Therapy"},{"key":"10.1016\/j.jep.2010.02.012_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0006-2952(03)00466-0","article-title":"Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1, rOAT3 and rOCT2","volume":"66","author":"Habu","year":"2003","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jep.2010.02.012_bib21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/0024-3205(90)90507-N","article-title":"Substituted cyclic imides as potential anti-gout agents","volume":"46","author":"Hall","year":"1990","journal-title":"Life Science"},{"key":"10.1016\/j.jep.2010.02.012_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physiol.00039.2004","article-title":"Molecular physiology of urate transport","volume":"20","author":"Hediger","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.jep.2010.02.012_bib23","first-page":"122","article-title":"Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney","volume":"276","author":"Hosoyamada","year":"1999","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.jep.2010.02.012_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.ASN.0000107560.80107.19","article-title":"Function and localization of urate transporter 1 in mouse kidney","volume":"15","author":"Hosoyamada","year":"2004","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1016\/j.jep.2010.02.012_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1523-1755.2003.00710.x","article-title":"Urate transport via human PAH transporter hOAT1 and its gene structure","volume":"63","author":"Ichida","year":"2003","journal-title":"Kidney International"},{"key":"10.1016\/j.jep.2010.02.012_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ASN.0000105320.04395.D0","article-title":"Clinical and molecular analysis of patients with renalhypouricemia in Japan-influence of URAT1 gene on urinary urate excretion","volume":"15","author":"Ichida","year":"2004","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1016\/j.jep.2010.02.012_bib27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ptr.1270","article-title":"Glycyrrhizin ameliorates renal function defects in the early-phase of ischemia-induced acute renal failure","volume":"17","author":"Kang","year":"2003","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.jep.2010.02.012_bib28","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/ndt\/gfn349","article-title":"SLC2A9--a fructose transporter identified as a novel uric acid transporter","volume":"23","author":"Le","year":"2008","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.jep.2010.02.012_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.jrn.2008.08.010","article-title":"Influence of renal function and diet on acid\u2013base status in chronic kidney disease patients","volume":"19","author":"Leal","year":"2009","journal-title":"Journal of Renal Nutrition"},{"key":"10.1016\/j.jep.2010.02.012_bib30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00002018-200831080-00002","article-title":"A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?","volume":"31","author":"Lee","year":"2008","journal-title":"Drug Safety"},{"key":"10.1016\/j.jep.2010.02.012_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbaexp.2004.10.001","article-title":"Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter","volume":"1681","author":"Li","year":"2004","journal-title":"Biochimica Biophysica Acta"},{"key":"10.1016\/j.jep.2010.02.012_bib32","first-page":"231","article-title":"Treatment of 43 cases of acute gouty arthritis with modified Simiao San","volume":"4","author":"Liang","year":"2009","journal-title":"Shandong Journal of Traditional Chinese Medicine"},{"key":"10.1016\/j.jep.2010.02.012_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11926-003-0072-y","article-title":"Hyperuricemia and gout","volume":"5","author":"Liot\u00e9","year":"2003","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.jep.2010.02.012_bib34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2008.11.001","article-title":"Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia","volume":"83","author":"Matsuo","year":"2008","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.jep.2010.02.012_bib35","first-page":"112","article-title":"Effect of extract of Cortex Phellodendri and Atractylodes lancea on hyperuricemia in mice","volume":"19","author":"Pan","year":"2008","journal-title":"Lishizhen Medicine And Materia Medica Research"},{"key":"10.1016\/j.jep.2010.02.012_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ng1339","article-title":"Functional variants of OCTN cation transporter genes are associated with Crohn disease","volume":"36","author":"Peltekova","year":"2004","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jep.2010.02.012_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/art.10792","article-title":"Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.jep.2010.02.012_bib38","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1073\/pnas.0904411106","article-title":"Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy","volume":"106","author":"Preitner","year":"2009","journal-title":"Proceedings of the National Academy of Science United States of America"},{"key":"10.1016\/j.jep.2010.02.012_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0254-6272(08)60023-0","article-title":"Treatment of 60 cases of gouty arthritis with modified Simiao Tang","volume":"28","author":"Qiu","year":"2008","journal-title":"Traditional Chinese Medicine"},{"key":"10.1016\/j.jep.2010.02.012_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2007.083071","article-title":"Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol","volume":"68","author":"Reinders","year":"2009","journal-title":"Annals of Rheumatic Disorder"},{"key":"10.1016\/j.jep.2010.02.012_bib41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.jep.2010.02.012_bib42","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1001\/jama.289.21.2857","article-title":"Gout","volume":"289","author":"Rott","year":"2003","journal-title":"Journal of American Medical Association"},{"key":"10.1016\/j.jep.2010.02.012_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/B:PHAM.0000012153.71993.cb","article-title":"Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases","volume":"21","author":"Sakurai","year":"2004","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.jep.2010.02.012_bib44","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","article-title":"Management of acute and chronic gouty arthritis: present state-of-the-art","volume":"64","author":"Schlesinger","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jep.2010.02.012_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3949\/ccjm.75.Suppl_5.S22","article-title":"The practical management of gout","volume":"75","author":"Schumacher","year":"2008","journal-title":"Cleve Clinical Journal of Medicine"},{"key":"10.1016\/j.jep.2010.02.012_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11655-007-9001-7","article-title":"Randomized and controlled clinical study of modified prescriptions of Simiao Pill in the treatment of acute gouty arthritis","volume":"14","author":"Shi","year":"2008","journal-title":"Chinese Journal of Integrated Medicine"},{"key":"10.1016\/j.jep.2010.02.012_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0031-6989(75)80015-4","article-title":"Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate","volume":"7","author":"Stavric","year":"1975","journal-title":"Pharmacology and Research Communication"},{"key":"10.1016\/j.jep.2010.02.012_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1267","article-title":"An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis","volume":"35","author":"Tokuhiro","year":"2003","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jep.2010.02.012_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ng.106","article-title":"SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout","volume":"40","author":"Vitart","year":"2008","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jep.2010.02.012_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2009.12.035","article-title":"The dual actions of Sanmiao wan as a hypouricemic agent: Down-regulation of hepatic XOD and renal mURAT1 in hyperuricemic mice","author":"Wang","year":"2010","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.jep.2010.02.012_bib51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1742-7843.2004.pto940506.x","article-title":"Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase\/oxidase activities in oxonate-treated mice","volume":"94","author":"Wang","year":"2004","journal-title":"Basic Clinical in Pharmacology and Toxicology"},{"key":"10.1016\/j.jep.2010.02.012_bib52","first-page":"1","article-title":"Dietary intake of ten key nutrients for public health, United States: 1999\u20132000","volume":"334","author":"Wright","year":"2003","journal-title":"Advance Data"}],"updated-by":[{"DOI":"10.1016\/j.jep.2021.114966","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000}}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874110001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874110001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T17:50:38Z","timestamp":1590688238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874110001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0378874110001273"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2010.02.012","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}